币界网报道:Biopharmaceutical company Synaptogenix (NASDAQ: SNPX) announced its first purchase of TAO, the specific purchase amount was not disclosed, which is part of the company's recently announced cryptocurrency financial strategy focusing on artificial intelligence (AI) and machine learning, and will select BitGo to provide qualified custody, staking and trading services for Synaptogenix's TAO assets. [Coin World]